Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.

NCT06000514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniasis, American

Interventions

DRUG: Sm29 Protein, Schistosoma Mansoni
DRUG: Pentavalent antimony (Sbv)

Sponsor

Hospital Universitário Professor Edgard Santos

Collaborators

[object Object]
[object Object]